Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biocept, Inc. (BIOCQ) had Revenue of $25.86M for the most recently reported fiscal year, ending 2022-12-31.

Quarterly Annual

Figures for fiscal year ending 2022-12-31

Income Statement Financials
Revenue	$25.86M
Net Income	$-32.09M
Cost of Goods Sold	$28.44M
Gross Profit	$-2.58M
Operating Expenses	$57.84M
Operating Income	$-31.98M
Non-Operating Income/Expense	$-0.23M
Pre-Tax Income	$-32.21M
Normalized Pre-Tax Income	$-32.21M
Income after Taxes	$-32.09M
Income from Continuous Operations	$-32.09M
Consolidated Net Income/Loss	$-32.09M
Normalized Income after Taxes	$-32.09M
EBIT	$-31.98M
EBITDA	$-30.33M
Weighted-Average Shares Outstanding (Basic)	0.56M
Weighted-Average Shares Outstanding (Diluted)	0.56M
Earnings per Share (EPS) (Basic)	$-56.76
Earnings per Share (EPS) (Diluted)	$-56.76
Balance Sheet Financials
Current Assets	$16.34M
Property, Plant, and Equipment	$2.57M
Long-Term Assets	$14.53M
Total Assets	$30.87M
Current Liabilities	$5.51M
Long-Term Debt	$1.20M
Long-Term Liabilities	$16.51M
Total Liabilities	$22.01M
Common Equity	$8.86M
Tangible Shareholders Equity	$8.86M
Shareholders Equity	$8.86M
Common Shares Outstanding	0.57M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-13.29M
Cash Flow from Investing Activities	$-0.81M
Cash Flow from Financial Activities	$-1.87M
Beginning Cash	$28.86M
End Cash	$12.90M
Increase/Decrease in Cash	$-15.97M
Stock-Based Compensation	$3.23M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.97
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.12
Debt to Equity Ratio	0.26
Gross Margin	-9.99%
Operating Margin	-123.69%
EBIT Margin	-123.69%
EBITDA Margin	-117.29%
Pre-Tax Profit Margin	-124.57%
Profit Margin	-124.09%
Free Cash Flow	$-14.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.84
Inventory Turnover	37.57
Receiveable Turnover	12.02
Days Sales in Receivables	30.36
Return on Equity	-362.16%
Return on Tangible Equity	-362.16%
Return on Assets	-103.93%
Return on Investments	-318.96%
Book Value Per Share	$15.59
Free Cash Flow per Share	$-24.97
Operating Cash Flow per Share	$-23.54

Data from Zacks Investment Research, Inc.